The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Sourcing · Payments

Documenting a payment dispute without naming and shaming — the long version

MA
mi.amankwahTL26 Feb 2026#1

Posting this under the heading it deserves: Documenting a payment dispute without naming and shaming — the long version Everything below is what sits behind that.

A narrow question about Documenting a payment dispute, deliberately narrow, because the broad version has been asked here four times and produced four long threads and no answer.

One question, stated units, stated method, and what I have already ruled out.

7 likes 6mo
QZ
q.zhao_qaTL3Quality assurance21 Apr 2026#2

This is the first time the answer has come with its own limits attached. Appreciated.

11 likes 3mo
IL
i.lehtinenTL213 Jun 2026#3

The site does not carry prices, payment details or transaction routes, and questions asking for them will be answered with that rather than with a link.

I would be interested in a counterexample if anyone has one.

32 likes 1mo

Suggested topics

TopicParticipantsRepliesViewsActivity
Why chargeback is not the safety net people assume
Asking directly, because I could not find a straight answer: Why chargeback is not the safety net people assume Asking about the record rather than the transfer. Every order leaves a trail: an order…
TNEDFLILBW+22 26 2.5k 2d
Coming back to: Payment mechanics and the recovery options that do not exist
On the subject in the title: Payment mechanics and the recovery options that do not exist Working notes rather than a conclusion. A payments question, with the mechanics separated from the money. What I would…
ZSSSLKDEK+7 11 2.6k 7mo
What to keep a record of at the point of payment
What to keep a record of at the point of payment — that is the question, and I have not found it answered plainly anywhere I have looked. A payments question, with the mechanics separated from the money. What…
HFBRAN 2 1.8k 16mo
Second pass at: Why chargeback is not the safety net people assume
Second pass at: Why chargeback is not the safety net people assume Writing it up because I had to work it out twice and would rather nobody else did. Asking about the record rather than the transfer. Every…
DBMMHB 2 25k 3mo
Payment mechanics and the recovery options that do not exist — what changed since
On the subject in the title: Payment mechanics and the recovery options that do not exist — what changed since Working notes rather than a conclusion. A payments question, with the mechanics separated from…
YRVBENBDCP+14 18 17k 13mo

Related topics — sharing the tags documentation quality, payments, research use only

TopicParticipantsRepliesViewsActivity
Batch numbers that do not match the vial label — what changed since
On the subject in the title: Batch numbers that do not match the vial label — what changed since Working notes rather than a conclusion. What changes if the standard account of Batch numbers is wrong? I ask…
MPAMBRSVC+39 43 14k 1mo
About the Payments category
Payment mechanics, chargeback reality, and the recurring risks. No payment facilitation of any kind here. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit is…
KHSSHKM 4 3.5k 20mo
AOD-9604 and the fragment hypothesis, revisited — does this still hold?
The question in the title: AOD-9604 and the fragment hypothesis, revisited — does this still hold? I will give what I have already checked below so nobody repeats it. What changes if the standard account of…
NLKKNRPFI+7 11 31k 19h
Labelling requirements for research chemicals — the long version
Posting this under the heading it deserves: Labelling requirements for research chemicals — the long version Everything below is what sits behind that. A narrow question about Labelling requirements for…
LSDBHK 2 1.8k 2mo
Coming back to: Reading a supplier's product description as a marketing document
Reading a supplier's product description as a marketing document Writing it up because I had to work it out twice and would rather nobody else did. Documentation question rather than a pharmacological one,…
HBELCVHNDN+35 39 688 5mo